| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/15/2011 | US7888508 3-(carboxy or carbamoyl)-5-amino-1H-pyrrolo(2,3-b)pyridines; cancer, Alzheimer's disease, viral infections, autoimmune diseases and neurodegenerative disorders; chemical libraries of these compounds |
| 02/15/2011 | US7888368 Treatment of drug-resistant tumors |
| 02/15/2011 | US7888344 Fused thiazole derivatives as kinase inhibitors |
| 02/15/2011 | US7888285 2,4,6-phenyl substituted cyclic ketoenols |
| 02/15/2011 | CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/15/2011 | CA2382132C Herbicidal composition |
| 02/15/2011 | CA2373554C Process for the preparation and purification of thiol-containing maytansinoids |
| 02/10/2011 | WO2011017142A1 Novel bicyclic urea compounds |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011015343A1 Metabotropic glutamate receptor modulators |
| 02/10/2011 | WO2011015241A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/10/2011 | WO2011014973A2 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/10/2011 | US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 02/10/2011 | US20110034437 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/10/2011 | CA2780829A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/10/2011 | CA2769245A1 Mesoionic pesticides |
| 02/10/2011 | CA2769124A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/10/2011 | CA2763956A1 Metabotropic glutamate receptor modulators |
| 02/09/2011 | EP2281819A1 Benzimidazolyl or benzoxazolyl derivatives |
| 02/09/2011 | EP2280981A1 Bridged heterocycles as hiv integrase inhibitors |
| 02/09/2011 | EP2280980A1 Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate |
| 02/09/2011 | EP2280970A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 02/09/2011 | EP1924579B1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 02/09/2011 | CN101970433A Gamma secretase modulators |
| 02/08/2011 | US7884099 such as (R)-5'-[3-{1-(4-{1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl-cyclopropyl]-methylamino}-piperidin-1-yl]-3'-hydroxy-benzoxazinorifamycin, useful as bactericides for the treatment of bacterial infections |
| 02/08/2011 | CA2605899C Triazole derivatives as vasopressin antagonists |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2374279C Process for the preparation of herbicidal derivatives |
| 02/03/2011 | WO2011014776A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
| 02/03/2011 | WO2011014774A1 Nitroimidazooxazines and their uses in anti-tubercular therapy |
| 02/03/2011 | WO2011013729A1 Fused imidazole derivative having ttk inhibitory action |
| 02/03/2011 | WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders |
| 02/03/2011 | WO2011012600A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines |
| 02/03/2011 | WO2010124042A3 Modulators of 5-ht receptors and methods of use thereof |
| 02/03/2011 | US20110028730 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands |
| 02/03/2011 | US20110028494 HCV NS3 Protease Inhibitors |
| 02/03/2011 | US20110028467 Heterocyclic derivatives |
| 02/03/2011 | US20110028466 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028450 Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines |
| 02/03/2011 | CA2769359A1 Nitroimidazooxazines and their uses in anti-tubercular therapy |
| 02/03/2011 | CA2769263A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
| 02/03/2011 | CA2769056A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279751A2 Stabilisation of macrolides |
| 02/02/2011 | EP2279737A1 Heterocyclic compounds that are active as beta lactamase inhibitors |
| 02/02/2011 | EP2279532A2 Oxazolobenzimidazole derivatives |
| 02/02/2011 | EP2089369B1 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 02/02/2011 | EP2032577B1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 02/02/2011 | CN101965354A Novel 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 02/02/2011 | CN101965353A Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones |
| 02/01/2011 | US7879891 Caspase inhibitor prodrugs |
| 02/01/2011 | US7879848 Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 02/01/2011 | US7879847 such as 4-(5,6-Dihydro-8H-imidazo[5,1-c][1,4]oxazin-5-yl)benzonitrile, having aldosterone synthase and/or 11- beta -hydroxylase inhibitory activity, used for the treatment of hypertension and Cushing's Syndrome |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 01/27/2011 | WO2011011508A1 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| 01/27/2011 | WO2011010744A1 Chromene compound |
| 01/27/2011 | WO2011009898A1 Fused aminodihydro-oxazine derivatives |
| 01/27/2011 | US20110021784 Methods for Preparing Diazonamides |
| 01/27/2011 | US20110021772 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 01/27/2011 | US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
| 01/27/2011 | US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives |
| 01/27/2011 | US20110021515 Dihyrofuropyrmindine compounds |
| 01/27/2011 | US20110021501 Substituted piperazino-dihydrothienopyrimidines |
| 01/27/2011 | US20110021500 Novel compounds |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021494 Novel tetrahydro-fused pyridines as histone deacetylase inhibitors |
| 01/27/2011 | US20110021492 Pyridazine derivatives as factor xia inhibitors |
| 01/27/2011 | US20110021473 Inhibitors of phosphodiesterase type-iv |
| 01/27/2011 | CA2768577A1 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| 01/26/2011 | EP2277898A2 Rapamycin analogues |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2277570A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277569A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277568A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277567A1 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277566A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277565A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2125830B1 New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6h)-one |
| 01/26/2011 | EP1697377B1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/26/2011 | CN101959893A Substituted arylamide oxazepinopyrimidone derivatives |
| 01/26/2011 | CN101486716B Preparation of rifampin |
| 01/25/2011 | US7875715 Compounds for the treatment of multi-drug resistant bacterial infections |
| 01/25/2011 | US7875639 Such as N-[3-(2-methoxyethyl)-1,3-thiazol-2(3H)-ylidene]adamantane-1-carboxamide; neuropathic, nociceptive and/or inflammatory pain; neuroprotection |
| 01/25/2011 | US7875627 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
| 01/25/2011 | US7875626 Therapeutic agents |
| 01/25/2011 | CA2535370C Isothiazoloquinolones and related compounds as anti-infective agents |
| 01/25/2011 | CA2410233C Compounds for treating impaired fundic relaxation |
| 01/20/2011 | WO2011009075A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | WO2011008172A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
| 01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | US20110015408 Sulfonylpyrrolidine modulators of androgen receptor function and method |
| 01/20/2011 | US20110015190 Gamma secretase modulators |
| 01/20/2011 | US20110015181 Alkylaminopyridine derivative |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015177 Substituted arylamide oxazepinopyrimidone derivatives |